New Members

Latest News and Announcements

Publications from Harvard Catalyst Profiles

Powered by Harvard Catalyst
  • Sun N, Lin CH, Li MY, Wang Y, Chen D, Ren X, Zhang F, Zhang Y. Clusterin drives myeloid bias in aged hematopoietic stem cells by regulating mitochondrial function. Nat Aging 2025. PubMed
  • Huang M, Wang D, Huang J, Bae AN, Xia Y, Zhao X, Mortaja M, Azin M, Collier MR, Semenov YR, Park JH, Demehri S. Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens. Nat Commun 2025; 16:5360. PubMed
  • El-Jawahri A, LeBlanc TW, Kavanaugh A, Webb J, Fausto J, Traeger L, Greer JA, Jackson V, Horick N, Rabideau DJ, Fenech A, Newcomb R, Ufere NN, Caruso E, Pepper J, DeFilipp Z, Chen YB, Lee SJ, Temel JS. Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation. J Clin Oncol 2025. PubMed
  • Kochenova OV, D'Alessandro G, Pilger D, Schmid E, Richards SL, Garcia MR, Jhujh SS, Voigt A, Gupta V, Carnie CJ, Alex Wu R, Gueorguieva N, Lam S, Stewart GS, Walter JC, Jackson SP. USP37 prevents premature disassembly of stressed replisomes by TRAIP. Nat Commun 2025; 16:5333. PubMed
  • Yates J, Mathey-Andrews C, Park J, Garza A, Gagné A, Hoffman S, Bi K, Titchen B, Hennessey C, Remland J, Carnes M, Shannon E, Camp S, Balamurali S, Cavale SK, Li Z, Raghawan AK, Kraft A, Boland G, Aguirre AJ, Sethi NS, Boeva V, Van Allen EM. Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma. Cell Rep Med 2025; 6:102188. PubMed
  • Yagi M, Bonilla G, Hoetker MS, Tsopoulidis N, Horng JE, Haggerty C, Meissner A, Sadreyev RI, Hock H, Hochedlinger K. Bivalent chromatin instructs lineage specification during hematopoiesis. Cell 2025. PubMed
  • Nardone C, Gao J, Seo HS, Mintseris J, Ort L, Yip MCJ, Negasi M, Besschetnova AK, Kamitaki N, Gygi SP, Dhe-Paganon S, Munshi NC, Fulciniti M, Greenberg ME, Shao S, Elledge SJ, Gu X. Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma. Mol Cell 2025. PubMed
  • Liu S, Li L, Zhang F, Garcia-Corral M, Meyer K, Fortuna PRJ, van Sambeek B, Appleton E, Ng AHM, Khoshakhlagh P, Lu YR, Cameron J, Ramirez RN, Chen Y, Wu CT, Huang JY, Tan Y, Chao G, Aach J, Lim ET, Tam JM, Raychaudhuri S, Church GM. Iterative transcription factor screening enables rapid generation of microglia-like cells from human iPSC. Nat Commun 2025; 16:5136. PubMed
  • Zhao T, He L, Wong LP, Mei S, Xia J, Xu Y, Van Vranken JG, Mazzola M, Chen L, Rhee C, Fang T, Fukushima T, Sayles LC, Diaz M, Gibbons JAB, Mostoslavsky R, Gygi SP, Dou Z, Sykes DB, Sadreyev RI, Sweet-Cordero EA, Scadden DT. Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogramming. Cell Metab 2025. PubMed
  • Olsen SN, Anderson B, Hatton C, Chu Z, Simpkins C, Wen Y, Bourgeois W, Haarer EL, Brown M, Jeselsohn R, Welm AL, Toska E, Armstrong SA. Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer. Cell Rep Med 2025. PubMed
  • Mittendorf EA, Assaf ZJ, Harbeck N, Zhang H, Saji S, Jung KH, Hegg R, Koehler A, Sohn J, Iwata H, Telli ML, Ferrario C, Punie K, Qamra A, Dieterich M, Xu Y, Liste-Hermoso M, Shearer-Kang E, Molinero L, Chui SY, Barrios CH. Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial. Nat Med 2025. PubMed
  • Bailey SR, Takei HN, Escobar G, Kann MC, Bouffard AA, Kienka T, Supper VM, Armstrong A, Salas-Benito D, Phillips MK, Birocchi F, Vatsa S, Silva H, Scarfò I, Wehrli M, Grauwet K, Darnell EP, Graham CE, Leick MB, Korell F, Berger TR, Maus MV. IFN-γ-resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models. Sci Transl Med 2025; 17:eadp8166. PubMed
  • Shah VS, Waghray A, Lin B, Bhagwat A, Monga I, Slyper M, Giotti B, Kim S, Sun D, Xu K, Park E, Bairakdar M, Xu J, Waldman J, Dionne D, Nguyen LT, Lou W, Cai P, Muus C, Sun J, Surve MV, Yang LCC, Rozenblatt-Rosen O, Delorey TM, Saladi SV, Regev A, Rajagopal J, Tsankov AM. Single cell profiling of human airway identifies tuft-ionocyte progenitor cells displaying cytokine-dependent differentiation bias in vitro. Nat Commun 2025; 16:5180. PubMed
  • Spiegel DY, Levey J, Modest A, Willcox J, Bhargava N, Sharma R, Recht A. Non-English Language Preference and Breast Cancer Outcomes. JAMA Netw Open 2025; 8:e2514036. PubMed
  • Clarke TL, Cho HM, Ceppi I, Gao B, Yadav T, Silveira GG, Boon R, Martinez-Pastor B, Amoh NYA, Machin B, Bernasocchi T, Ashfaq D, Mendez J, Kamaliyan Z, Del Río Pantoja J, Rogines GS, Crowley BT, McGinn DE, Giunta V, Tran O, Zackai EH, Lan L, Zou L, Emanuel BS, McDonald-McGinn DM, Cejka P, Mostoslavsky R. ZNF280A links DNA double-strand break repair to human 22q11.2 distal deletion syndrome. Nat Cell Biol 2025; 27:1006-1020. PubMed
  • Piotrowska Z, Passaro A, Nguyen D, Ruiter G, Soo RA, Ho-Fun Lee V, Velcheti V, Shao-Weng Tan D, Lee SH, Kim SH, Wrangle J, Chih-Hsin Yang J, Daga H, Juan Vidal OJ, Spira AI, Fernandez-Hinojal G, Kim SW, Umemura S, Pulla MP, Keeton EK, Yang ZS, Li S, Xu ZC, Jones JA, Yu HA, . Zipalertinib in Patients With Exon 20 Insertion-Positive NSCLC Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab. J Clin Oncol 2025. PubMed
  • Gallifant J, Chen S, Jain SK, Moreira P, Topaloglu U, Aerts HJWL, Warner JL, La Cava WG, Bitterman DS. Reliability of Large Language Model Knowledge Across Brand and Generic Cancer Drug Names. JCO Clin Cancer Inform 2025; 9:e2400257. PubMed
  • Li Z, Peluffo G, Stevens LE, Qiu X, Seehawer M, Tawawalla A, Huang XY, Egri SB, Raval S, McFadden M, D'Santos CS, Papachristou E, Kingston NL, Nishida J, Evans KE, Seo JH, Clement K, Temko D, Ekram M, Li R, Rees MG, Ronan MM, Roth JA, Simeonov A, Kales SC, Rai G, Lal-Nag M, Maloney DJ, Jadhav A, Michor F, Meissner A, Balko JM, Carroll JS, Freedman ML, Jaffe JD, Papanastasiou M, Long HW, Polyak K. KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage. Nat Genet 2025; 57:1463-1477. PubMed
  • Jacobs JM, Traeger L, Freese M, Barata A, Newcomb R, Rabideau D, Horick N, DeFilipp Z, Chen YB, Gray T, Pepper J, Caruso E, Amonoo HL, Lee SJ, Greer JA, Temel JS, El-Jawahri A. BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. J Clin Oncol 2025. PubMed
  • Varkaris A, Wang K, Nouri M, Kozlova N, Schmidt DR, Stavridi A, Arai S, Ambrosio N, Poluben L, Jimenez-Vacas JM, Westaby D, Carmichael J, Xie F, Figueiredo I, Buroni L, Neeb A, Gurel B, Chevalier N, Brown L, Voznesensky O, Chen SY, Russo JW, Yuan X, Juric D, Beltran H, De Bono JS, Vander Heiden MG, Einstein DJ, Muranen T, Corey E, Sharp A, Balk SP. BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress. Nat Commun 2025; 16:4931. PubMed
  • Warner K, Hunkeler M, Baek K, Schmoker A, Roy Burman SS, Overwijn D, Jin C, Donovan KA, Fischer ES. Structural ubiquitin contributes to K48 linkage specificity of the HECT ligase Tom1. Cell Rep 2025; 44:115688. PubMed
  • Beck A, Gabler-Pamer L, Alencastro Veiga Cruzeiro G, Lambo S, Englinger B, Shaw ML, Hack OA, Liu I, Haase RD, de Biagi CAO, Baumgartner A, Nascimento Silva AD, Klenner M, Freidel PS, Herms J, von Baumgarten L, Tonn JC, Thon N, Bruckner K, Madlener S, Mayr L, Senfter D, Peyrl A, Slavc I, Lötsch D, Dorfer C, Geyregger R, Amberg N, Haberler C, Mack N, Schwalm B, Pfister SM, Korshunov A, Baird LC, Yang E, Chi SN, Alexandrescu S, Gojo J, Kool M, Hovestadt V, Filbin MG. Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions. Nat Cancer 2025. PubMed
  • Cheloni G, Karagkouni D, Pita-Juarez Y, Torres D, Kanata E, Liegel J, Avigan Z, Saldarriaga I, Chedid G, Rallis K, Miles B, Tiwari G, Kim J, Mattie M, Rosenblatt J, Vlachos IS, Avigan D. Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire. Nat Commun 2025; 16:4819. PubMed
  • Morelli E, Aktas Samur A, Maisano D, Gao C, Favasuli VK, Papaioannou D, De Nola G, Henninger JE, Liu N, Turi M, Folino P, Vreux L, Cumerlato M, Chen L, Aifantis I, Fulciniti M, Anderson KC, Lytton-Jean AK, Gulla A, Young R, Samur MK, Munshi NC. CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs. Blood 2025. PubMed
  • Rogers CM, Kaur H, Swift ML, Raina VB, Zhou S, Kawale AS, Syed S, Kelly KG, Jasper AM, Salunkhe S, Kwon Y, Wang J, Shabestari AB, Daley JM, Sacks A, Gaczynska ME, Osmulski PA, Rawal Y, Tomimatsu N, Gayther SA, Lawrenson K, Burma S, Wasmuth EV, Olsen SK, Zhao W, Hromas R, Libich DS, Mazin AV, Zhou D, Greene EC, Chowdhury D, Sung P. CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade. Science 2025; 388:881-888. PubMed
  • Zhu B, Gao S, Chen S, Wang Y, Yeung J, Bai Y, Huang AY, Yeo YY, Liao G, Mao S, Jiang ZG, Rodig SJ, Wong KC, Shalek AK, Nolan GP, Jiang S, Ma Z. CellLENS enables cross-domain information fusion for enhanced cell population delineation in single-cell spatial omics data. Nat Immunol 2025. PubMed
  • Alberge JB, Dutta AK, Poletti A, Coorens THH, Lightbody ED, Toenges R, Loinaz X, Wallin S, Dunford A, Priebe O, Dagan J, Boehner CJ, Horowitz E, Su NK, Barr H, Hevenor L, Towle K, Beesam R, Beckwith JB, Perry J, Cordas Dos Santos DM, Bertamini L, Greipp PT, Kübler K, Arndt PF, Terragna C, Zamagni E, Boyle EM, Yong K, Morgan G, Walker BA, Dimopoulos MA, Kastritis E, Hess J, Sklavenitis-Pistofidis R, Stewart C, Getz G, Ghobrial IM. Genomic landscape of multiple myeloma and its precursor conditions. Nat Genet 2025. PubMed
  • Sim ES, Rhoades J, Xiong K, Walsh L, Crnjac A, Blewett T, Al-Inaya Y, Mendel J, Ruiz-Torres DA, Efthymiou V, Lumaj G, Benjamin WJ, Makrigiorgos GM, Tabrizi S, Adalsteinsson VA, Faden DL. Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck Cancer. Clin Cancer Res 2025. PubMed
  • Yuan WC, Earl AS, Ma S, Alcedo K, Russell JO, Duarte FM, Chu YT, Chang PC, Chen HY, Chi HH, Zhu Q, Rodriguez-Fraticelli AE, Patel SH, Lee YR, Buenrostro JD, Camargo FD. HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury. Cell Stem Cell 2025. PubMed
  • Sherman MS, McMahon-Skates T, Gaston LS, Katzen SW, Majzoub JA, Goessling W. Harmonizing TUNEL with multiplexed iterative immunofluorescence enriches spatial contextualization of cell death. Cell Rep Methods 2025; 5:101047. PubMed
  • Sept CE, Tak YE, Goel V, Bhakta MS, Cerda-Smith CG, Hutchinson HM, Blanchette M, Eyler CE, Johnstone SE, Joung JK, Hansen AS, Aryee MJ. High-resolution CTCF footprinting reveals impact of chromatin state on cohesin extrusion. Nat Commun 2025; 16:4506. PubMed
  • Dusetzina SB, Jazowski SA, Nayak RK, Huskamp HA, Keating NL. Trends in Launch Prices and Price Increases for Self-Administered Anticancer Drugs in Medicare. JAMA 2025. PubMed
  • Barroso-Sousa R, Zanudo JGT, Li T, Reddy SM, Emens LA, Kuntz TM, Silva CAC, AlDubayan SH, Chu H, Overmoyer B, Lange P, DiLullo MK, Montesion M, Kasparian J, Hughes ME, Attaya V, Basta A, Lin NU, Tayob N, Jeselsohn R, Mittendorf EA, Tolaney SM. Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS). Nat Commun 2025; 16:4430. PubMed
  • Bonnet J, Cernik C, Uno H, Xu L, Laurent CA, Fisher L, Cannizzaro N, Munneke J, Cooper RM, Lakin JR, Schwartz CM, Casperson M, Altschuler A, Kushi LH, Chao CR, Wiener L, Mack JW. Timing and Outcomes of Palliative Care Integration Into Care of Adolescents and Young Adults With Advanced Cancer. JCO Oncol Pract 2025. PubMed
  • Ely ZA, Kulstad ZJ, Gunaydin G, Addepalli S, Verzani EK, Casarrubios M, Clauser KR, Wang X, Lippincott IE, Louvet C, Schmitt T, Kapner KS, Agus MP, Hennessey CJ, Cleary JM, Hadrup SR, Klaeger S, Su J, Jaeger AM, Wolpin BM, Raghavan S, Smith EL, Greenberg PD, Aguirre AJ, Abelin JG, Carr SA, Jacks T, Freed-Pastor WA. Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition. Science 2025; 388:eadk3487. PubMed
  • Bontempi D, Zalay O, Bitterman DS, Birkbak N, Shyr D, Haugg F, Qian JM, Roberts H, Perni S, Prudente V, Pai S, Dekker A, Haibe-Kains B, Guthier C, Balboni T, Warren L, Krishan M, Kann BH, Swanton C, De Ruysscher D, Mak RH, Aerts HJWL. FaceAge, a deep learning system to estimate biological age from face photographs to improve prognostication: a model development and validation study. Lancet Digit Health 2025. PubMed
  • Boeszoermenyi A, Radeva DL, Schindler S, Valadares V, Padmanabha Das KM, Dubey A, Viennet T, Schmitt M, Kast P, Gelev VM, Stoyanov N, Burdzhiev N, Petrov O, Ficarro S, Marto J, Geffken EA, Dhe-Paganon S, Seo HS, Alexander ND, Cooley RB, Mehl RA, Kovacs H, Anklin C, Bermel W, Kuprov I, Takeuchi K, Arthanari H. Leveraging relaxation-optimized H-C correlations in 4-F-phenylalanine as atomic beacons for probing structure and dynamics of large proteins. Nat Chem 2025. PubMed
  • Li C, Syed MU, Nimbalkar A, Shen Y, Vieira MD, Fraser C, Inde Z, Qin X, Ouyang J, Kreuzer J, Clark SE, Kelley G, Hensley EM, Morris R, Lazaro R, Belmonte B, Oh A, Walcott M, Nabel CS, Caenepeel S, Saiki AY, Rex K, Lipford JR, Heist RS, Lin JJ, Haas W, Sarosiek K, Hughes PE, Hata AN. LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers. Nat Commun 2025; 16:4112. PubMed
  • Tak D, Garomsa BA, Zapaishchykova A, Ye Z, Vajapeyam S, Mahootiha M, Pardo JCC, Smith C, Familiar AM, Chaunzwa TL, Liu KX, Prabhu SP, Bandopadhayay P, Nabavizadeh A, Mueller S, Aerts HJWL, Haas-Kogan D, Poussaint TY, Kann BH. Longitudinal Risk Prediction for Pediatric Glioma with Temporal Deep Learning. NEJM AI 2025. PubMed
  • Spitzer A, Johnson KC, Nomura M, Garofano L, Nehar-Belaid D, Darnell NG, Greenwald AC, Bussema L, Oh YT, Varn FS, D'Angelo F, Gritsch S, Anderson KJ, Migliozzi S, Gonzalez Castro LN, Chowdhury T, Robine N, Reeves C, Park JB, Lipsa A, Hertel F, Golebiewska A, Niclou SP, Nusrat L, Kellet S, Das S, Moon HE, Paek SH, Bielle F, Laurenge A, Di Stefano AL, Mathon B, Picca A, Sanson M, Tanaka S, Saito N, Ashley DM, Keir ST, Ligon KL, Huse JT, Yung WKA, Lasorella A, Iavarone A, Verhaak RGW, Tirosh I, Suvà ML. Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics. Nat Genet 2025; 57:1168-1178. PubMed
  • Nomura M, Spitzer A, Johnson KC, Garofano L, Nehar-Belaid D, Galili Darnell N, Greenwald AC, Bussema L, Oh YT, Varn FS, D'Angelo F, Gritsch S, Anderson KJ, Migliozzi S, Gonzalez Castro LN, ChowdhFury T, Robine N, Reeves C, Park JB, Lipsa A, Hertel F, Golebiewska A, Niclou SP, Nusrat L, Kellet S, Das S, Moon HE, Paek SH, Bielle F, Laurenge A, Di Stefano AL, Mathon B, Picca A, Sanson M, Tanaka S, Saito N, Ashley DM, Keir ST, Ligon KL, Huse JT, Yung WKA, Lasorella A, Verhaak RGW, Iavarone A, Suvà ML, Tirosh I. The multilayered transcriptional architecture of glioblastoma ecosystems. Nat Genet 2025; 57:1155-1167. PubMed
  • Otuya DO, Farrokhi H, Verma Y, Dong J, Choy P, Kumar A, Shore RE, Zemlok SK, Sevieri E, Schellenberg M, Spicer G, Lopez DR, Osman HA, Gardecki JA, Kyrollos Kelada AAF, Gao AH, Chung A, Grant CN, Bhat NGM, Rosenberg M, Jacobson BC, Nishioka NS, Colson Y, Tearney GJ. A thin cryobiopsy device compatible with transnasal endoscopy for the gastrointestinal tract. Sci Transl Med 2025; 17:eado9609. PubMed
  • Yu KKH, Basu S, Baquer G, Ahn R, Gantchev J, Jindal S, Regan MS, Abou-Mrad Z, Prabhu MC, Williams MJ, D'Souza AD, Malinowski SW, Hopland K, Elhanati Y, Stopka SA, Stortchevoi A, Couturier C, He Z, Sun J, Chen Y, Espejo AB, Chow KH, Yerrum S, Kao PL, Kerrigan BP, Norberg L, Nielsen D, , Puduvalli VK, Huse J, Beroukhim R, Kim BYS, Goswami S, Boire A, Frisken S, Cima MJ, Holdhoff M, Lucas CG, Bettegowda C, Levine SS, Bale TA, Brennan C, Reardon DA, Lang FF, Chiocca EA, Ligon KL, White FM, Sharma P, Tabar V, Agar NYR. Investigative needle core biopsies support multimodal deep-data generation in glioblastoma. Nat Commun 2025; 16:3957. PubMed
  • George BM, Eleftheriou M, Yankova E, Perr J, Chai P, Nestola G, Almahayni K, Evans S, Damaskou A, Hemberger H, Lebedenko CG, Rak J, Yu Q, Bapcum E, Russell J, Bagri J, Volk RF, Spiekermann M, Stone RM, Giotopoulos G, Huntly BJP, Baxter J, Camargo F, Liu J, Zaro BW, Vassiliou GS, Möckl L, de la Rosa J, Flynn RA, Tzelepis K. Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein. Nat Biotechnol 2025. PubMed
  • Liu JF, Colombo N, Oza AM, Frenel JS, Corr BR, Rubinstein MM, Nevadunsky NS, Lheureux S, Gaba L, González Cortijo L, Salutari V, You B, Chiang S, O'Connor MJ, Oplustil O'Connor L, Meulendijks D, Khatun M, Ghiorghiu D, Oaknin A. ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma. J Clin Oncol 2025. PubMed
  • Rigotti NA, Benowitz NL, Prochaska JJ, Rubinstein M, Clarke A, Blumenstein B, Cain DF, Jacobs C. Cytisinicline for Smoking Cessation: The ORCA Phase 3 Replication Randomized Clinical Trial. JAMA Intern Med 2025. PubMed
  • Teng M, Guo J, Xu X, Ci X, Mo Y, Kohen Y, Ni Z, Chen S, Guo WY, Bakht M, Ku S, Sigouros M, Luo W, Macarios CM, Xia Z, Chen M, Ul Haq S, Yang W, Berlin A, van der Kwast T, Ellis L, Zoubeidi A, Zheng G, Ming J, Wang Y, Cui H, Lok BH, Raught B, Beltran H, Qin J, He HH. Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation. Cancer Cell 2025. PubMed
  • van Schaik TA, Chen KS, Kanaya N, Moreno-Lama L, Freeman NW, Wang M, Li W, Zhang YS, Vrbanac V, Huang R, Wakimoto H, Reardon D, Shah K. Anti-tumor immunity mediated by engineered allogeneic stem cells exploiting TRAIL-induced cell death and FLT3L immunomodulation. Clin Cancer Res 2025. PubMed
  • Nguyen LD, Sengupta S, Cho KI, Floru A, George RE, Krichevsky AM. A drug that induces the microRNA miR-124 enables differentiation of retinoic acid-resistant neuroblastoma cells. Sci Signal 2025; 18:eads2641. PubMed
  • Oka T, Smith SS, Oliver-Garcia VS, Lee T, Son HG, Mortaja M, Azin M, Garza-Mayers AC, Huang JT, Nazarian RM, Horn TD, Demehri S. Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Rep 2025. PubMed
Hide